 | Up a level |
2020
Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Fruehwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I, Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F. H., Theissen, J., Volland, R., Hero, B. and Simon, T. (2020). Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Ann. Oncol., 31 (3). S. 422 - 430. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2017
Klein, H., Volland, R., Ehren, R., Habbig, S., Liebau, M. C., Nuesken, K. D., Taylan, C. and Weber, L. T. (2017). STEROID WITHDRAWAL WITHIN THE FIRST YEAR AFTER PEDIATRIC KIDNEY TRANSPLANTATION - ELEVATED RISK FOR THE DEVELOPMENT OF DE NOVO DONOR-SPECIFIC ANTIBODIES (DNDSA) AND ACUTE REJECTION EPISODES (ARE)? Pediatr. Transplant., 21. S. 21 - 22. HOBOKEN: WILEY. ISSN 1399-3046
2016
Matthies, J., Huenseler, C., Ehren, R., Volland, R., Koerber, F., Hoppe, B., Weber, L. T. and Habbig, S. (2016). Extrarenal Manifestations in Shigatoxin-associated Haemolytic Uremic Syndrome. Klinische Padiatr., 228 (4). S. 181 - 189. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3824
2015
Berthold, F., Volland, R., Proleskovskaya, I., Mazanek, P., Belogurova, M., Hoemberg, M., Simon, T., Hero, B. and Sterba, J. (2015). METRONOMIC THERAPY AS LOW TOXIC AND EFFECTIVE TREATMENT FOR RECURRENCES OF HIGH RISK NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S178 - 1. HOBOKEN: WILEY. ISSN 1545-5017
Deubzer, H., Fabian, J., Opitz, D., Althoff, K., Lodrini, M., Astrahantseff, K., Hero, B., Volland, R., Beckers, A., De Preter, K., Patil, N., Abba, M., Wuenchel, J., Thole, T., Hu, J., Schweitzer, L., Mechtersheimer, G., Carter, D., Cheung, B., Popanda, O., von Deimling, A., Henrich, K. O., Westermann, F., Schwab, M., Koster, J., Versteeg, R., Marshall, G., Speleman, F., Zoeller, M., Allgayer, H., Fischer, M., Berthold, F., Kulozik, A., Witt, O., Schulte, J. and Eggert, A. (2015). MYCN TRANSCRIPTIONALLY REPRESSES CD9 TO TRIGGER AN INVASION-METASTASIS CASCADE IN NEUROBLASTOMA. Pediatr. Blood Cancer, 62. S. S150 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Hero, B., Simon, T., Volland, R., Eggert, A., Fischer, M. and Berthold, F. (2015). BENIGN COURSE OF DISEASE IN LOCALIZED NEUROBLASTOMA SHOWING RELAPSE OR PROGRESSION. Pediatr. Blood Cancer, 62. S. S178 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
Volland, R., Simon, T., Berthold, F. and Hero, B. (2015). CONFIRMATION OF THE INRG SURVIVAL TREE ANALYSIS BY A DIFFERENTLY COMPOSED REPRESENTATIVE NATIONAL COHORT OF PATIENTS. Pediatr. Blood Cancer, 62. S. S226 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1545-5017
2014
Ikram, F., Ackermann, S., Roels, E., Volland, R., Hero, B., Hertwig, F., Kocak, H., Dreidax, D., Henrich, K. O., Berthold, F., Nuernberg, P., Westermann, F. and Fischer, M. (2014). Transcription factor activating protein 2 beta (TFAP2B) mediates neuronal differentiation in neuroblastoma. Eur. J. Cancer, 50. S. 130 - 132. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852